Aridis Pharmaceuticals, Inc.
ARDSDelisted Sep 8, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001614067
Aridis Pharmaceuticals, Inc. was delisted on Sep 8, 2023; its insiders filed their last Form 4 on Jun 28, 2024; 18 institutions reported holding it in 13F filings for Q2 2023, worth $392.3K in total; no superinvestor held it.
13F holders, Q4 2021
Institutional positions in Aridis Pharmaceuticals, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- +2 vs. Q3 2021
- Shares held
- 1.27M
- −721.6K (−36.2%) vs. Q3 2021
- Total value
- $2.96M
- −$4.37M (−59.6%) vs. Q3 2021
- New holders
- 8
- 6 more added
- Sold out
- 6
- 1 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARDS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $0 |
| Q1 2026 | 1 | $1 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 1 | $3 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 2 | $10 |
| Q3 2023 | 1 | $1.44K |
| Q2 2023 | 18 | $392.3K |
| Q1 2023 | 20 | $1.29M |
| Q4 2022 | 17 | $4.58M |
| Q3 2022 | 16 | $1.79M |
| Q2 2022 | 19 | $2.05M |
| Q1 2022 | 22 | $3.38M |
| Q4 2021 | 20 | $2.96M |
| Q3 2021 | 18 | $7.33M |
| Q2 2021 | 13 | $7.87M |
| Q1 2021 | 12 | $5.97M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Aridis Pharmaceuticals, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 507,337 | $1.18M | 0.00% | +337,800+199.2% | Added |
| Roumell Asset Management, LLC | 446,588 | $1.04M | 1.39% | +99,071+28.5% | Added |
| Susquehanna International Group, LLP | 54,670 | $127.0K | 0.00% | +54,670 | New |
| BlackRock Inc. | 43,201 | $101.0K | 0.00% | +974+2.3% | Added |
| Jane Street Group, LLC | 39,680 | $92.0K | 0.00% | +39,680 | New |
| Geode Capital Management, LLC | 37,974 | $88.0K | 0.00% | +2,075+5.8% | Added |
| State Street Corp | 26,447 | $62.0K | 0.00% | 00.0% | Unchanged |
| Perritt Capital Management Inc | 24,000 | $56.0K | 0.03% | +8,000+50.0% | Added |
| Commonwealth Equity Services, LLC | 20,200 | $47.0K | 0.00% | +20,200 | New |
| Northern Trust Corp | 16,572 | $39.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 14,734 | $34.0K | 0.00% | +14,734 | New |
| Wealth Architects, LLC | 14,077 | $33.0K | 0.01% | 00.0% | Unchanged |
| Virtu Financial LLC | 12,200 | $28.0K | 0.00% | +12,200 | New |
| Advisor Group Holdings, Inc. | 9,000 | $21.0K | 0.00% | +9,000 | New |
| Wells Fargo & Company | 1,294 | $3.00K | 0.00% | +23+1.8% | Added |
| Citigroup Inc | 750 | $2.00K | 0.00% | 00.0% | Unchanged |
| Cutler Group LP | 700 | $1.00K | 0.00% | +700 | New |
| Financial Perspectives, Inc | 250 | $583 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 213 | $0 | 0.00% | −1,486−87.5% | Reduced |
| Focused Wealth Management, Inc | 100 | $0 | 0.00% | +100 | New |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −1,068,444−100.0% | Sold out |
| AIGH Capital Management LLC | 0 | $0 | 0.00% | −150,591−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −74,559−100.0% | Sold out |
| Minot Wealth Management LLC | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −600−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −100−100.0% | Sold out |